Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Gains from Investment Securities (2023 - 2025)

Monte Rosa Therapeutics' Gains from Investment Securities history spans 3 years, with the latest figure at $14.9 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 2825.8% year-over-year to $14.9 million; the TTM value through Sep 2025 reached $14.9 million, up 2825.8%, while the annual FY2025 figure was $14.1 million, 21.36% up from the prior year.
  • Gains from Investment Securities reached $14.9 million in Q3 2025 per GLUE's latest filing, up from $208031.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $15.2 million in Q1 2025 to a low of $208031.0 in Q2 2025.
  • Average Gains from Investment Securities over 3 years is $5.3 million, with a median of $575126.5 recorded in 2023.
  • The largest YoY upside for Gains from Investment Securities was 2825.8% in 2025 against a maximum downside of 54.04% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at $639512.0 in 2023, then fell by 20.14% to $510741.0 in 2024, then soared by 2825.8% to $14.9 million in 2025.
  • Per Business Quant, the three most recent readings for GLUE's Gains from Investment Securities are $14.9 million (Q3 2025), $208031.0 (Q2 2025), and $15.2 million (Q1 2025).